The in Vitro Antiplasmodial and Antiproliferative Activity of New Ferrocene‐Based α‐Aminocresols Targeting Hemozoin Inhibition and DNA Interaction
Authors:
- Mziyanda MbabaMMMziyanda Mbaba
- Laura M. K. DingleLDLaura M. K. Dingle
- Tarryn SwartTSTarryn Swart
- Devon CashDCDevon Cash
- Dustin LamingDLDustin Laming
- Jo‐Anne de la MareJMJo‐Anne de la Mare
- Dale TaylorDTDale Taylor
- Heinrich C. HoppeHHHeinrich C. Hoppe
- Christophe BiotCBChristophe Biot
- Adrienne L. EdkinsAdrienne L. Edkins
- Setshaba D. KhanyeSKSetshaba D. Khanye
- 19 April 2020
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 21 (18) , 2643-2658
Abstract
The conjugation of organometallic complexes to known bioactive organic frameworks is a proven strategy revered for devising new drug molecules with novel modes of action. This approach holds great promise for the generation of potent drug leads in the quest for therapeutic chemotypes with the potential to overcome the development of clinical resistance. Herein, we present the in vitro antiplasmodial and antiproliferative investigation of ferrocenyl α‐aminocresol conjugates assembled by amalgamation of the organometallic ferrocene unit and an α‐aminocresol scaffold possessing antimalarial activity. The compounds pursued in the study exhibited higher toxicity towards the chemosensitive (3D7) and ‐resistant (Dd2) strains of the Plasmodium falciparum parasite than to the human HCC70 triple‐negative breast cancer cell line. Indication of cross‐resistance was absent for the compounds evaluated against the multi‐resistant Dd2 strain. Structure‐activity analysis revealed that the phenolic hydroxy group and rotatable σ bond between the α‐carbon and NH group of the α‐amino‐o‐cresol skeleton are crucial for the biological activity of the compounds. Spectrophotometric techniques and in silico docking simulations performed on selected derivatives suggest that the compounds show a dual mode of action involving hemozoin inhibition and DNA interaction via minor‐groove binding. Lastly, compound 9 a, identified as a possible lead, exhibited preferential binding for the plasmodial DNA isolated from 3D7 P. falciparum trophozoites over the mammalian calf thymus DNA, thereby substantiating the enhanced antiplasmodial activity of the compounds. The presented research demonstrates the strategy of incorporating organometallic complexes into known biologically active organic scaffolds as a viable avenue to fashion novel multimodal compounds with potential to counter the development drug resistance.Keywords
This publication has 62 references indexed in Scilit:
- Route to three-dimensional fragments using diversity-oriented synthesisProceedings of the National Academy of Sciences, 2011
- The Antimalarial Ferroquine: Role of the Metal and Intramolecular Hydrogen Bond in Activity and ResistanceACS Chemical Biology, 2010
- Theory of docking scores and its application to a customizable scoring functionSAR and QSAR in Environmental Research, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Pharmacogenomic analyses of targeting the AT-rich malaria parasite genome with AT-specific alkylating drugsMolecular and Biochemical Parasitology, 2007
- Incorporation of an Intramolecular Hydrogen-Bonding Motif in the Side Chain of 4-Aminoquinolines Enhances Activity against Drug-Resistant P. falciparumJournal of Medicinal Chemistry, 2006
- Mechanisms of Cancer Drug ResistanceAnnual Review of Medicine, 2002
- Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures1The Journal of Organic Chemistry, 1996
- Human Malaria Parasites in Continuous CultureScience, 1976
- Aminoalkylphenols as Antimalarials. I. Simply Substituted α-Aminocresols1Journal of the American Chemical Society, 1946